These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9305719)

  • 1. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
    Lawrence W; Anderson JR; Gehan EA; Maurer H
    Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
    Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
    Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that influence treatment decisions in childhood rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Group of the Children's Cancer Group, the Pediatric Oncology Group, and the Intergroup Rhabdomyosarcoma Study Group Statistical Center.
    Donaldson SS; Anderson J
    Radiology; 1997 Apr; 203(1):17-22. PubMed ID: 9122388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II).
    Lawrence W; Gehan EA; Hays DM; Beltangady M; Maurer HM
    J Clin Oncol; 1987 Jan; 5(1):46-54. PubMed ID: 3543238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in children with rhabdomyosarcoma.
    Gehan EA; Glover FN; Maurer HM; Sutow WW; Hays DM; Lawrence W; Newton WA; Soule EH
    Natl Cancer Inst Monogr; 1981 Apr; (56):83-92. PubMed ID: 7029299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
    Nguyen TV; Yueh B
    Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in head and neck rhabdomyosarcoma.
    Simon JH; Paulino AC; Smith RB; Buatti JM
    Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdomyosarcoma: the Stanford experience using a TNM staging system.
    Pedrick TJ; Donaldson SS; Cox RS
    J Clin Oncol; 1986 Mar; 4(3):370-8. PubMed ID: 3950676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997).
    Neville HL; Andrassy RJ; Lobe TE; Bagwell CE; Anderson JR; Womer RB; Crist WM; Wiener ES
    J Pediatr Surg; 2000 Feb; 35(2):317-21. PubMed ID: 10693687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turkish experience with rhabdomyosarcoma: an analysis of 255 patients for 20 years.
    Akyüz C; Sancak R; Büyükpamukçu N; Atahan L; Göğüş S; Kutluk T; Büyükpamukçu M
    Turk J Pediatr; 1998; 40(4):491-501. PubMed ID: 10028857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.
    Andrassy RJ; Corpron CA; Hays D; Raney RB; Wiener ES; Lawrence W; Lobe TE; Bagwell C; Maurer HM
    J Pediatr Surg; 1996 Jan; 31(1):191-6. PubMed ID: 8632278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyosarcoma in children and adolescents. A review.
    Ruymann FB
    Hematol Oncol Clin North Am; 1987 Dec; 1(4):621-54. PubMed ID: 3323176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal-paranasal-oronasopharyngeal lymphomas in childhood: the role of staging system on prognosis.
    Yariş N; Kutluk T; Yalçin B; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2000; 17(5):345-53. PubMed ID: 10914044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
    Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
    J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of prognostic factors in rhabdomyosarcoma. Preliminary univariate and multivariate results of the Cooperative Soft Tissue Sarcoma Study (CWS-81)].
    Suder J; Stienen U; Kaatsch P; Harms D; Schmidt D; Spaar HJ; Treuner J
    Klin Padiatr; 1986; 198(3):218-23. PubMed ID: 3523027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
    Smith LM; Anderson JR; Qualman SJ; Crist WM; Paidas CN; Teot LA; Pappo AS; Link MP; Grier HE; Wiener ES; Breneman JC; Raney RB; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Oct; 19(20):4058-64. PubMed ID: 11600608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TNM staging system of lung carcinoma: historical notes, limitations and controversies].
    Motta G; Nahum MA; Testa T; Spinelli E
    Ann Ital Chir; 1995; 66(4):425-32. PubMed ID: 8686992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
    Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
    J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?
    Wiener ES; Anderson JR; Ojimba JI; Lobe TE; Paidas C; Andrassy RJ; Raney RB; Qualman SJ; Donaldson SS; Maurer HM; Link MP; Crist WM; Grier HE
    Semin Pediatr Surg; 2001 Aug; 10(3):146-52. PubMed ID: 11481652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.